BIOL Stock Alert: 14 Things for Potential Investors to Know About Biolase

Biolase (NASDAQ:BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers.

an image of a tooth among various dentistry implements. dental stocks to buy

Source: Shutterstock

Here’s everything investors need to know about Biolase today as its stock soars higher.

  • Biolase signed a deal with Dental Care Alliance to bring its dental lasers to its members.
  • That will result in all of the organization’s affiliates adopting its dental lasers and starting hands-on training for them this year.
  • Dental Care Alliance is one of the largest dental support organizations in the U.S. with 330 affiliated practices across 20 states.
  • Biolase is a medical device company with a focus on dentistry and medicine.
  • This has it handling the development, manufacturing, marketing, and sales of its products.
  • Biolase laser products are proprietary and are protected by about 271 patents and 40 patent-pending technologies.
  • The company has sold more than 41,200 of its laser systems in more than 80 countries.
  • It was founded in 1984 and is currently lead by its president and CEO Todd Norbe.
  • Norbe joined the company in 2018 and took on the role of CEO shortly afterward.
  • Prior to this, he held executive positions at KaVo Kerr, a subsidiary of Danaher (NYSE:DHR).
  • BIOL stock is seeing heavy trading following today’s news.
  • As of this writing, more than 170 million shares have changed hands.
  • To put that in perspective, the company’s daily average trading volume is 11.43 million shares.
  • Its current market capitalization is sitting at roughly $83 million.

BIOL stock was up 51.8% as of Tuesday afternoon.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Article printed from InvestorPlace Media,

©2022 InvestorPlace Media, LLC